REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania
Clinical trial NCT06170671 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06170671
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-12-13
- Primary completion
- 2028-09-30
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.